Cost-related Non-adherence to Medications among Patients with Diabetes and Chronic Pain: Factors beyond Finances
- Jacob E. Kurlander, MD, MS1,
- Eve A. Kerr, MD, MPH2,3,4,
- Sarah Krein, PhD, RN2,3,4,
- Michele Heisler, MD, MPA2,3,4 and
- John D. Piette, PhD (jpiette{at}umich.edu)2,3,4
- 1University of Michigan Medical School, Ann Arbor, MI
- 2Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI
- 3Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI
- 4Michigan Diabetes Research and Training Center, University of Michigan, Ann Arbor, MI
Abstract
Objective: In the face of financial constraints, diabetes patients may forgo prescribed medications, causing negative health effects. This study examined how cost and non-cost factors are associated with patterns of cost-related non-adherence to medications (CRN).
Research Design and Methods: Cross-sectional survey of patients using medications for both diabetes and chronic pain (N=245). Patients reported their income, out-of-pocket medication costs, education level, depressive symptoms, medication-related beliefs, and whether they cut back due to cost on 1) both diabetes and pain medications, 2) diabetes medications only, 3) pain medications only, or 4) neither. Multinomial logistic regression was used to model patients' adjusted odds-ratios (AORs) of falling into these four possible categories.
Results: Nine percent of patients cut back on medications for both conditions, 13% cut back on diabetes medications alone, and 9% cut back on pain medications alone. Income <$20,000 (AOR=5.7, p=0.008) and monthly medication costs >$50 (AOR=3.9, p=0.02) increased patients' odds of CRN for both conditions versus neither. Low-income patients also were more likely to selectively forgo pain medications (AOR=9.1, p=0.001) but not diabetes medications (AOR=2.1, p=0.12). More depressive symptoms (AOR=1.6, p=0.006) and negative medication-related beliefs (AOR=1.7, p=0.02) increased patients' odds of cutting back selectively on medications for diabetes but not pain.
Conclusions: Patients who forgo medications for both diabetes and chronic pain appear to be influenced primarily by economic pressures, while patients who cut back selectively on their diabetes treatments are influenced by their mood and medication beliefs. Our findings point toward more targeted strategies to assist diabetes patients who experience CRN.
Footnotes
-
- Received June 10, 2009.
- Accepted August 19, 2009.
- Copyright © American Diabetes Association











